# Arthrosi Therapeutics, Inc. — Form D

Arthrosi Therapeutics, Inc. of LAGUNA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-24. The offering totals $153.1M, of which $60.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-06-24
- Form: D
- Accession: 0001741062-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $153.1M
- Amount sold: $60.9M
- Remaining: $92.2M
- Investors: 13
- Date of first sale: 2025-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-549632

## Issuer

- Name: Arthrosi Therapeutics, Inc.
- CIK: 0001741062
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 23052 ALCALDE DRIVE, SUITE A, LAGUNA HILLS, CA, 92653
- Phone: 7148130709

## Officers, directors & promoters (26)

_Showing 25 of 26 people._

| Name | Role | Location |
| --- | --- | --- |
| Thomas Huang | Director | San Diego, CA |
| John Leaman | Director | San Diego, CA |
| Hanxiong Li | Director | San Diego, CA |
| Zhang Mingyuan | Director | San Diego, CA |
| Xiaodong Wang | Director | Yarrow Point, WA |
| Xin Xie | Director | San Diego, CA |
| Shunqi Yan | Director | San Diego, CA |
| Litain Yeh | Director | San Diego, CA |
| Chaohua Yuan | Director | San Diego, CA |
| Shunqi Yan | Executive Officer | San Diego, CA |
| Litain Yeh | Executive Officer | San Diego, CA |
| Shunqi Yan | Promoter | San Diego, CA |
| Litain Yeh | Promoter | San Diego, CA |
| ROBERT ORR | Director | Halifax, A5 |
| ROBERT ORR | Executive Officer | Halifax, A5 |
| ROBERT ORR | Promoter | Halifax, A5 |
| James Mackay | Director | San Diego, CA |
| James McKay | Director | Laguna Hills, CA |
| Xiaojia Cai | Director | Laguna Hills, CA |
| Yiwei Zong | Director | Laguna Hills, CA |
| Cynthia Cai | Director | Laguna Hills, CA |
| Xie Xin | Director | Laguna Hills, CA |
| Yiwei Zhong | Director | Laguna Hills, CA |
| Li Hanxiong | Director | Laguna Hills, CA |
| Jianhua Cai | Director | San Diego, CA |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-01-26](https://search.stillhousedata.com/formd/0001741062-24-000001) | D | $75.0M | $7.0M |
| [2023-03-03](https://search.stillhousedata.com/formd/0001741062-23-000001) | D | $20.0M | $15.0M |
| [2021-11-15](https://search.stillhousedata.com/formd/0001741062-21-000002) | D | $30.0M | $26.0M |
| [2021-11-15](https://search.stillhousedata.com/formd/0001741062-21-000001) | D | $220K | $220K |
| [2020-06-03](https://search.stillhousedata.com/formd/0001741062-20-000001) | D | $20.0M | $8.5M |
| [2019-01-30](https://search.stillhousedata.com/formd/0001741062-19-000001) | D | $11.0M | $11.0M |
| [2018-06-29](https://search.stillhousedata.com/formd/0001741062-18-000001) | D | $4.3M | $4.3M |

## More

- [CIK 1741062 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1741062&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001741062-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.